Pathogen: Influenza A(H5N1) virus

PANTHER

United Kingdom
|
2024
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Baricitinib
  • Simvastatin
  • Immnunomodulator

EU-PROACT

France Norway Spain Belgium Italy United Kingdom Ireland Austria The Netherlands Switzerland
|
2025
  • Adults
  • General population
  • Hospital wide
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Flu

ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
|
2021
  • Adults
  • Primary care
  • Community
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray

ECRAID-REMAP-CAP

Belgium Croatia Czech Republic Estonia France Germany Hungary Ireland Italy The Netherlands Portugal Serbia Slovenia Spain Switzerland United Kingdom
|
2018
  • Adults
  • Paediatric
  • Hospital wide
  • Intensive care unit
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Post-COVID-19
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Oseltamivir
  • Baloxavir
  • Corticosteroid
  • Immnunomodulator

ECRAID-EU-RECOVERY

France Italy The Netherlands Belgium Estonia Portugal Romania Spain Sweden
|
2020
  • Adults
  • Paediatric
  • Hospital wide
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Oseltamivir
  • Baloxavir
  • Corticosteroid
  • Antivirals

Sanz-Munoz

Spain
|
2021-2022
  • Adults
  • Elderly
  • General population
  • Non-hospital health centre
  • Community
  • Long-term care facility
  • Influenza A(H5N1) virus
  • Influenza virus
  • Influenza A(H7N9) virus
  • Avian Influenza
  • Vaccination
  • Pharmacological intervention